Skip to main content

Primary and Metastatic Liver Tumors

Treatment Strategy and Evolving Therapies

  • Book
  • © 2018

Overview

  • Provides a comprehensive, state-of-the art review of the current landscape of systemic and liver-directed therapy for malignant liver tumors
  • Provides new insight into novel and evolving therapies in the areas of surgical technique and liver-directed arterial based and ablative therapies
  • Written by experts in their fields

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (28 chapters)

  1. Introduction

  2. Primary Liver Tumors

  3. Metastatic Liver Tumors

Keywords

About this book

The incidence of primary and metastatic liver tumors is rising and the therapeutic armamentarium for these tumors is expanding at a rapid pace. Surgery remains the primary treatment modality for these tumors. With improvements in our perioperative management and operative techniques a larger proportion of patients are able to undergo potentially curative liver surgery. In addition, indications and criteria for liver transplantation for both primary and metastatic liver tumors are constantly expanding. Unfortunately, many patients are not amendable to surgical resection or liver transplantation and therefore alternative liver-directed therapies are routinely being implemented as part of complex multidisciplinary treatment models.   However, these models are continually evolving as these regional therapeutic options continue to expand. New embolization agents and techniques, as well as, improvements in radiation delivery, are all evolving in the background of improvement in systemic and targeted therapy options for these tumors. 


This book provides a comprehensive, state-of-the art review of the current state of liver-directed therapy for malignant liver tumors. The book will serve as a valuable resource for not only surgeons and clinicians but for researchers with an interest in malignant liver tumors.  The book focuses on the therapeutic approach to primary and metastatic tumors providing an up-to-date review on surgical liver anatomy and new imaging techniques as well as patient selection and technical consideration for resection and transplantation. In addition, the book provides new insight into novel and evolving therapies in the areas of transarterial therapy such as: (i) bland embolization, (ii) chemoembolization, and (iii) radioembolization; as well as new radiation techniques including SBRT and proton therapy.  Furthermore, the expanding role of hepatic artery infusion therapy in primary malignant tumorsis highlighted. Finally, integration of all these regional therapy options with upcoming and evolving systemic and targeted therapy regimens are integrated and discussed. 
  
This book will serve as a very useful resource for clinicians and researchers managing and treating patients with these challenging malignancies.  It provides a concise yet comprehensive summary of the current status of the field that will help guide patient management and stimulate investigative efforts. All chapters are written by experts in their fields and include the most up to date scientific and clinical information. 


Reviews

“This book covers treatment strategies for a variety of primary and metastatic liver tumors. Emerging modalities and combinations of therapies are covered extremely well. … This is a high-quality book that will stand beside other comprehensive books. It does not compete with any existing high-quality textbooks, but rather provides an additional depth of detail needed by subspecialists.” (Carol Scott-Conner, Doody's Book Reviews, April 12, 2019)

Editors and Affiliations

  • Division of Surgical Oncology, Winship Cancer Institute, Emory University Hospital Midtown, Atlanta, USA

    Kenneth Cardona

  • Division of Surgical Oncology, Winship Cancer Institute, Emory University Hospital, Atlanta, USA

    Shishir K. Maithel

About the editors

Kenneth Cardona, MD FACS
Associate Professor of Surgery
Division of Surgical Oncology
Winship Cancer Institute
Emory University School of Medicine
550 Peachtree St., NE
Atlanta, GA 30308


Shishir K. Maithel, MD FACS
Professor of Surgery
Division of Surgical Oncology
Winship Cancer Institute 
Emory University School of Medicine
1365 Clifton Rd., NE
Atlanta, GA 30322




Bibliographic Information

  • Book Title: Primary and Metastatic Liver Tumors

  • Book Subtitle: Treatment Strategy and Evolving Therapies

  • Editors: Kenneth Cardona, Shishir K. Maithel

  • DOI: https://doi.org/10.1007/978-3-319-91977-5

  • Publisher: Springer Cham

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer Nature Switzerland AG 2018

  • Hardcover ISBN: 978-3-319-91976-8Published: 16 October 2018

  • Softcover ISBN: 978-3-030-06339-9Published: 21 December 2018

  • eBook ISBN: 978-3-319-91977-5Published: 01 October 2018

  • Edition Number: 1

  • Number of Pages: XVII, 395

  • Number of Illustrations: 36 b/w illustrations, 29 illustrations in colour

  • Topics: General Surgery, Surgical Oncology, Oncology, Interventional Radiology

Publish with us